About FDA
Emails received, reviewed, and vetted by OCI during the month
Dictionary: OCI’s “Report Suspected Criminal Activity” webpage hosted on the OCI homepage and linked through the FDA website offers the public the ability to report suspected fraudulent and criminal activity concerning FDA regulated products. Criminal activity reported through this link are investigated by OCI and referred to the ORA OE Consumer Protection Fraud Team for regulatory follow up as warranted.
Information is current as of February 12, 2013.
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 111 |
| Nov 2011 | N/A | 123 |
| Dec 2011 | N/A | 115 |
| Jan 2012 | N/A | 135 |
| Feb 2012 | N/A | 128 |
| Mar 2012 | N/A | 143 |
| Apr 2012 | N/A | 115 |
| May 2012 | N/A | 147 |
| Jun 2012 | N/A | 134 |
| Jul 2012 | N/A | 136 |
| Aug 2012 | N/A | 114 |
| Sep 2012 | N/A | 87 |
FY 2012 Total: 1,488
Information received from the web page referred to Centers, District Office ORA for regulatory action during the month
Dictionary: Number of emails received through OCI “Report Suspected Criminal Activity” webpage link that are reviewed, vetted, and referred to regulatory divisions within FDA for action other than criminal in the reported month.
Fiscal Year - 2012
| Time | Target | Number |
|---|---|---|
| Oct 2011 | N/A | 20 |
| Nov 2011 | N/A | 21 |
| Dec 2011 | N/A | 41 |
| Jan 2012 | N/A | 56 |
| Feb 2012 | N/A | 60 |
| Mar 2012 | N/A | 59 |
| Apr 2012 | N/A | 58 |
| May 2012 | N/A | 56 |
| Jun 2012 | N/A | 29 |
| Jul 2012 | N/A | 45 |
| Aug 2012 | N/A | 42 |
| Sep 2012 | N/A | 24 |
FY 2012 YTD: 511
Glossary
Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.







